All manuscripts
Publications NK Cells G-Rex®100M G-Rex®24 Well Plate G-Rex®6M Well Plate

PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

Published Journal Frontiers in Immunology

Share
18 pages PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival — Frontiers in Immunology, 2024

Overview

This study combined PM21-particles with IL-12/15/18 (CAP) to expand NK cells. CAP-NK cells showed superior expansion in G-Rex® 24, G-Rex® 6M, and G-Rex® 100M. The resulting cells exhibited memory-like properties, enhanced metabolic fitness, and improved in vivo persistence compared to PM21 alone.

What this paper found

Adding IL-12, IL-15 and IL-18 to PM21-particle stimulation (the CAP method) markedly increased ex vivo expansion of human NK cells from healthy-donor PBMC. Over 14 days, CAP-NK cells expanded a mean 8200-fold versus 1100-fold with PM21-particles alone, and doubled faster on day 9 (18 vs 27 h). In 24-well G-Rex® bioreactors left untouched for 7 days, CAP-NK cells expanded an average 41-fold versus 6-fold for PM21-NK cells, and two donors reached 11,500- and 10,800-fold by day 14 after transfer to larger G-Rex® formats. CAP-NK cells expressed more 4-1BB and CD25, killed SKOV-3 and A549 cancer cells more effectively, had higher basal glycolysis and maximal respiration, survived better without cytokines after a 7-day rest (85% vs 35% recovery) and persisted better in NSG mice.

Note: Preclinical study in cancer cell lines and NSG mice using healthy-donor NK cells; the 14-day scale-up into larger G-Rex® formats was carried out for two donors.

Taken as a whole, these data demonstrate that CAP-NK cells persist better, are cytotoxic after prolonged rest and exhibit memory-like responses upon restimulation. — Jeremiah L. Oyer, Tayler J. Croom-Perez, Md Faqrul Hasan, Javier A. Rivera-Huertas, Sarah B. Gitto, Joanna M. Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik, Frontiers in Immunology

Study details

Authors
Jeremiah L. Oyer, Tayler J. Croom-Perez, Md Faqrul Hasan, Javier A. Rivera-Huertas, Sarah B. Gitto, Joanna M. Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik
Institution
Burnett School of Biomedical Science, College of Medicine, University of Central Florida, Orlando, FL, United States
Journal
Frontiers in Immunology
Year
2024
PMID / PMC
PMID: 38711506 · PMC
G-Rex® model(s)
G-Rex®100M, G-Rex®24 Well Plate, G-Rex®6M Well Plate
Cell type(s)
NK Cells
Application area
Hematologic malignancy · Solid tumor
Study phase
Preclinical

How G-Rex® was used

T-cell-depleted PBMC were seeded in G-Rex®24 (a 24-well G-Rex® bioreactor) with IL-2 and PM21-particles, with or without IL-12/15/18, and left untouched for 7 days; CAP-NK cells expanded an average 41-fold versus 6-fold for PM21-NK cells, with media glucose monitored from day 5. Cultures were then transferred to T-flasks, G-Rex®6M or G-Rex®100M and grown for another 7 days. For two donors, CAP cultures moved to a larger G-Rex® format reached 11,500- and 10,800-fold expansion by day 14.

Note: In the G-Rex® cultures, IL-12/15/18, PM21-particles and IL-2 were added together at the start without a cytokine wash step, unlike the overnight cytokine pre-activation followed by a wash used for the 14-day 8200-fold expansion.

Explore related

Full citation

Oyer JL, Croom-Perez TJ, Hasan MF, et al. PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival. Front Immunol. 2024;15:1383281.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →